7884 Accounts 2010 Accounts 2010 02 06 2010 16:36 Page 114 114 Financials BTG plc Annual Report and Accounts 2010 Five-year financial record For the years ended 31 March Consolidated income statement 2010 2009 2008 2007 2006 m m m m m Revenue 98.5 84.8 75.0 45.7 50.2 Cost of sales 32.8 37.1 32.1 18.9 20.7 Gross profit 65.7 47.7 42.9 26.8 29.5 Operating and administrative expenses 29.3 20.6 13.8 18.9 24.3 Amortisation of business combination intangibles 9.1 3.0 Operating expenses 38.4 23.6 13.8 18.9 24.3 Research and development 26.7 21.2 12.2 9.0 8.1 Share of results of associates 0.3 0.4 0.7 0.7 1.0 Research and development expenses 27.0 21.6 12.9 9.7 9.1 Profit on disposal of assets and investments 1.1 2.6 0.4 2.7 11.6 Amounts written off associates and investments 3.4 1.0 4.2 Restructuring costs 0.7 10.9 8.1 1.0 3.7 Operating profit loss 2.1 9.2 8.5 0.9 0.2 Net financial income expense 7.0 2.1 2.2 1.7 1.7 Profit loss before tax 9.1 11.3 10.7 2.6 1.5 Tax 2.2 1.8 1.9 0.2 0.1 Profit loss after tax for the year 11.3 13.1 8.8 2.4 1.4 Attributable to: Equity holders of the parent 11.3 13.1 8.8 2.4 1.5 Minority interest 0.1 Profit loss after tax for the year 11.3 13.1 8.8 2.4 1.4 Basic and diluted earnings loss per share 4.4p 7.1p 5.9p 1.6p 1.0p Gross profit 1 2010 2009 2008 2007 2006 m m m m m Royalties from launched products 38.0 32.1 24.9 24.2 23.0 Income from new agreements and milestone payments 8.6 11.0 18.0 2.6 6.5 Gross profit from marketed products 19.1 4.6 Gross profit 65.7 47.7 42.9 26.8 29.5 The results for the year ended 31 March 2009 include the results of Protherics from the date of acquisition, being 4 December 2008.
1 28.7 43.5 Total equity and liabilities 311.0 329.4 86.3 76.0 85.7 The balance sheet for 31 March 2009 includes the assets and liabilities acquired from Protherics during the year.
Consolidated cash flow statement 2010 2009 2008 2007 2006 m m m m m Net cash inflow outflow from operating activities 5.8 1.8 13.4 3.1 7.0 Net cash outflow inflow from investing activities 2.6 21.8 0.8 5.4 19.1 Net cash from financing activities 1.4 0.1 0.8 4.3 Increase decrease in cash and cash equivalents 4.6 19.9 14.2 7.7 16.4 Effect of exchange rate fluctuations on cash held 0.2 1.3 0.2 0.3 0.1 Cash and cash equivalents at start of year 78.2 57.0 43.0 51.0 34.5 Cash and cash equivalents at end of year 82.6 78.2 57.0 43.0 51.0 The results for the year ended 31 March 2009 include the results of Protherics from the date of acquisition, being 4 December 2008.
